Lilly deepens ties with Gate Bioscience in $870m deal expansion

PartnershipPositive

AI Analysis

Summary

Eli Lilly expanded its partnership with Gate Bioscience with an $870 million deal to further develop Gate's molecular gate technology platform for targeting difficult-to-drug proteins.

Outcome Details

$870 million deal expansion

Importance:6/10

Sentiment:

0.60

partnershipdeal expansionmolecular gate technologydrug discovery platform

Related Companies

$LLY

Read the original article

Published by Pharmaceutical Technology on October 6, 2026 10:33 AM

Read Original